ClearPoint Neuro, Inc.

CLPT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$18,914-$22,089-$16,435-$14,410
Dep. & Amort.$1,903$1,514$777$692
Deferred Tax$0$0$0$202
Stock-Based Comp.$6,907$6,079$0$2,078
Change in WC$1,399-$1,404-$4,289-$1,684
Other Non-Cash-$245$2,180$3,780$425
Operating Cash Flow-$8,950-$13,720-$16,167-$12,697
Investing Activities
PP&E Inv.-$275-$717-$1,146-$168
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$21,590$0
Inv. Sales/Matur.$0$0$12,000$0
Other Inv. Act.$0$9,666$0$0
Investing Cash Flow-$275$8,949-$10,736-$168
Financing Activities
Debt Repay.-$10,000$0$0$0
Stock Issued$16,149$0$745$46,785
Stock Repurch.$0-$210$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$40$506-$336$90
Financing Cash Flow$6,189$296$409$46,875
Forex Effect$0$0$0$0
Net Chg. in Cash-$3,036-$4,475-$26,494$34,010
Supplemental Information
Beg. Cash$23,140$27,615$54,109$20,099
End Cash$20,104$23,140$27,615$54,109
Free Cash Flow-$9,225-$14,437-$16,420-$12,865